Report Overview
Report Overview
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patients cells instead of using drugs or surgery.The Drug Based on Gene Therapy market is primarily driven by the revolutionary potential of gene therapy to address genetic disorders at their root cause, offering a new paradigm for treating previously incurable conditions. Gene therapy involves introducing genetic material into a patients cells to correct or replace faulty genes, aiming to restore normal cellular function. The increasing understanding of the genetic basis of diseases, coupled with advancements in gene delivery methods and genome editing techniques, contributes to market growth. Moreover, the demonstrated benefits of gene therapy in providing targeted and long-lasting treatments, overcoming limitations of traditional pharmacological approaches, and offering hope to patients with rare genetic disorders further propel adoption. However, challenges include optimizing gene delivery efficiency, addressing potential immune responses, and ensuring the long-term safety and durability of gene-based treatments. Navigating regulatory pathways, conducting rigorous clinical trials, and addressing ethical considerations are ongoing concerns. The markets success relies on continuous research in genetic medicine, collaborations between biotechnology companies and research institutions, and comprehensive education on the benefits and potential challenges of using gene therapy-based drugs while addressing the evolving challenges associated with precision medicine and personalized treatments.
The global Gene Therapy on Cancer market size was estimated at USD 8251.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 39.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gene Therapy on Cancer market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gene Therapy on Cancer market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gene Therapy on Cancer market.
Global Gene Therapy on Cancer Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Gilead Sciences
Amgen
Shanghai Sunway
Sibiono
Market Segmentation (by Type)
Viral Gene Therapy
Non-viral Gene Therapy
Market Segmentation (by Application)
Hospital
Clinic
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Therapy on Cancer Market
Overview of the regional outlook of the Gene Therapy on Cancer Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Therapy on Cancer Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Therapy on Cancer, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Gene Therapy on Cancer
- 1.2 Key Market Segments
- 1.2.1 Gene Therapy on Cancer Segment by Type
- 1.2.2 Gene Therapy on Cancer Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Gene Therapy on Cancer Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Gene Therapy on Cancer Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Gene Therapy on Cancer Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 2.1 Global Market Overview
- 3 Gene Therapy on Cancer Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Gene Therapy on Cancer Product Life Cycle
- 3.3 Global Gene Therapy on Cancer Sales by Manufacturers (2020-2025)
- 3.4 Global Gene Therapy on Cancer Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Gene Therapy on Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Gene Therapy on Cancer Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Gene Therapy on Cancer Market Competitive Situation and Trends
- 3.8.1 Gene Therapy on Cancer Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Gene Therapy on Cancer Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Gene Therapy on Cancer Industry Chain Analysis
- 4.1 Gene Therapy on Cancer Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Gene Therapy on Cancer Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Gene Therapy on Cancer Market Porters Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Gene Therapy on Cancer Market
- 5.7 ESG Ratings of Leading Companies
- 6 Gene Therapy on Cancer Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Gene Therapy on Cancer Sales Market Share by Type (2020-2025)
- 6.3 Global Gene Therapy on Cancer Market Size by Type (2020-2025)
- 6.4 Global Gene Therapy on Cancer Price by Type (2020-2025)
- 7 Gene Therapy on Cancer Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Gene Therapy on Cancer Market Sales by Application (2020-2025)
- 7.3 Global Gene Therapy on Cancer Market Size (M USD) by Application (2020-2025)
- 7.4 Global Gene Therapy on Cancer Sales Growth Rate by Application (2020-2025)
- 8 Gene Therapy on Cancer Market Sales by Region
- 8.1 Global Gene Therapy on Cancer Sales by Region
- 8.1.1 Global Gene Therapy on Cancer Sales by Region
- 8.1.2 Global Gene Therapy on Cancer Sales Market Share by Region
- 8.2 Global Gene Therapy on Cancer Market Size by Region
- 8.2.1 Global Gene Therapy on Cancer Market Size by Region
- 8.2.2 Global Gene Therapy on Cancer Market Size by Region
- 8.3 North America
- 8.3.1 North America Gene Therapy on Cancer Sales by Country
- 8.3.2 North America Gene Therapy on Cancer Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Gene Therapy on Cancer Sales by Country
- 8.4.2 Europe Gene Therapy on Cancer Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Gene Therapy on Cancer Sales by Region
- 8.5.2 Asia Pacific Gene Therapy on Cancer Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Gene Therapy on Cancer Sales by Country
- 8.6.2 South America Gene Therapy on Cancer Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Gene Therapy on Cancer Sales by Region
- 8.7.2 Middle East and Africa Gene Therapy on Cancer Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 8.1 Global Gene Therapy on Cancer Sales by Region
- 9 Gene Therapy on Cancer Market Production by Region
- 9.1 Global Production of Gene Therapy on Cancer by Region(2020-2025)
- 9.2 Global Gene Therapy on Cancer Revenue Market Share by Region (2020-2025)
- 9.3 Global Gene Therapy on Cancer Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Gene Therapy on Cancer Production
- 9.4.1 North America Gene Therapy on Cancer Production Growth Rate (2020-2025)
- 9.4.2 North America Gene Therapy on Cancer Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Gene Therapy on Cancer Production
- 9.5.1 Europe Gene Therapy on Cancer Production Growth Rate (2020-2025)
- 9.5.2 Europe Gene Therapy on Cancer Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Gene Therapy on Cancer Production (2020-2025)
- 9.6.1 Japan Gene Therapy on Cancer Production Growth Rate (2020-2025)
- 9.6.2 Japan Gene Therapy on Cancer Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Gene Therapy on Cancer Production (2020-2025)
- 9.7.1 China Gene Therapy on Cancer Production Growth Rate (2020-2025)
- 9.7.2 China Gene Therapy on Cancer Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Novartis
- 10.1.1 Novartis Basic Information
- 10.1.2 Novartis Gene Therapy on Cancer Product Overview
- 10.1.3 Novartis Gene Therapy on Cancer Product Market Performance
- 10.1.4 Novartis Business Overview
- 10.1.5 Novartis SWOT Analysis
- 10.1.6 Novartis Recent Developments
- 10.2 Gilead Sciences
- 10.2.1 Gilead Sciences Basic Information
- 10.2.2 Gilead Sciences Gene Therapy on Cancer Product Overview
- 10.2.3 Gilead Sciences Gene Therapy on Cancer Product Market Performance
- 10.2.4 Gilead Sciences Business Overview
- 10.2.5 Gilead Sciences SWOT Analysis
- 10.2.6 Gilead Sciences Recent Developments
- 10.3 Amgen
- 10.3.1 Amgen Basic Information
- 10.3.2 Amgen Gene Therapy on Cancer Product Overview
- 10.3.3 Amgen Gene Therapy on Cancer Product Market Performance
- 10.3.4 Amgen Business Overview
- 10.3.5 Amgen SWOT Analysis
- 10.3.6 Amgen Recent Developments
- 10.4 Shanghai Sunway
- 10.4.1 Shanghai Sunway Basic Information
- 10.4.2 Shanghai Sunway Gene Therapy on Cancer Product Overview
- 10.4.3 Shanghai Sunway Gene Therapy on Cancer Product Market Performance
- 10.4.4 Shanghai Sunway Business Overview
- 10.4.5 Shanghai Sunway Recent Developments
- 10.5 Sibiono
- 10.5.1 Sibiono Basic Information
- 10.5.2 Sibiono Gene Therapy on Cancer Product Overview
- 10.5.3 Sibiono Gene Therapy on Cancer Product Market Performance
- 10.5.4 Sibiono Business Overview
- 10.5.5 Sibiono Recent Developments
- 10.1 Novartis
- 11 Gene Therapy on Cancer Market Forecast by Region
- 11.1 Global Gene Therapy on Cancer Market Size Forecast
- 11.2 Global Gene Therapy on Cancer Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Gene Therapy on Cancer Market Size Forecast by Country
- 11.2.3 Asia Pacific Gene Therapy on Cancer Market Size Forecast by Region
- 11.2.4 South America Gene Therapy on Cancer Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Gene Therapy on Cancer by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Gene Therapy on Cancer Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Gene Therapy on Cancer by Type (2026-2035)
- 12.1.2 Global Gene Therapy on Cancer Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Gene Therapy on Cancer by Type (2026-2035)
- 12.2 Global Gene Therapy on Cancer Market Forecast by Application (2026-2035)
- 12.2.1 Global Gene Therapy on Cancer Sales (K MT) Forecast by Application
- 12.2.2 Global Gene Therapy on Cancer Market Size (M USD) Forecast by Application (2026-2035)
- 12.1 Global Gene Therapy on Cancer Market Forecast by Type (2026-2035)
- 13 Conclusion and Key Findings